Artemis Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Artemis Wealth Advisors's GILD Position: Q4 2023 in Review
Artemis Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 573 shares — an estimated $42.9K sold.
Artemis Wealth Advisors first reported a position in GILD in Q1 2017 and held it in 27 quarters. The position peaked at $47.8K in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Artemis Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- Artemis Wealth Advisors sold 573 Gilead Sciences shares in Q4 2023, an estimated $42.9K.
- Artemis Wealth Advisors first reported a position in Gilead Sciences in Q1 2017 and held it in 27 quarters.
- Artemis Wealth Advisors's Gilead Sciences position peaked at $47.8K in Q4 2022.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Artemis Wealth Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.